A detailed history of Landaas & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Landaas & CO holds 4,702 shares of ABBV stock, worth $842,598. This represents 0.26% of its overall portfolio holdings.

Number of Shares
4,702
Previous 4,702 -0.0%
Holding current value
$842,598
Previous $806,000 15.14%
% of portfolio
0.26%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $28,481 - $33,259
184 Added 4.07%
4,702 $806,000
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $141,440 - $161,158
-885 Reduced 16.38%
4,518 $822,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $73,753 - $83,063
536 Added 11.01%
5,403 $837,000
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $22,526 - $28,033
-170 Reduced 3.38%
4,867 $655,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $28,922 - $33,308
-200 Reduced 3.82%
5,037 $802,000
Q4 2022

Feb 15, 2023

SELL
$138.31 - $165.87 $38,035 - $45,614
-275 Reduced 4.99%
5,237 $846,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $4,965 - $5,695
-37 Reduced 0.67%
5,512 $740,000
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $9,633 - $12,247
70 Added 1.28%
5,549 $850,000
Q2 2021

Aug 17, 2021

SELL
$105.21 - $117.21 $10,521 - $11,721
-100 Reduced 1.79%
5,479 $617,000
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $25,575 - $28,155
250 Added 4.69%
5,579 $604,000
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $528,518 - $620,306
-6,152 Reduced 53.58%
5,329 $467,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $7,337 - $9,818
100 Added 0.88%
11,481 $1.13 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $31,448 - $39,349
-436 Reduced 3.69%
11,381 $1.01 Million
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $4,912 - $5,906
-78 Reduced 0.66%
11,817 $895,000
Q2 2019

Jul 29, 2019

SELL
$65.7 - $83.98 $12,745 - $16,292
-194 Reduced 1.6%
11,895 $865,000
Q1 2019

Apr 19, 2019

BUY
$77.14 - $90.79 $857,411 - $1.01 Million
11,115 Added 1141.17%
12,089 $974,000
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $848,848 - $999,053
-11,004 Reduced 91.87%
974 $974,000
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $7,084 - $8,736
-91 Reduced 0.75%
11,978 $1.1 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $711 - $790
8 Added 0.07%
12,069 $1.14 Million
Q2 2018

Aug 07, 2018

SELL
$89.78 - $106.23 $8,349 - $9,879
-93 Reduced 0.77%
12,061 $1.12 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $9,661 - $12,937
105 Added 0.87%
12,154 $1.15 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $71,200 - $78,076
-795 Reduced 6.19%
12,049 $1.17 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $897,153 - $1.15 Million
12,844
12,844 $1.14 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Landaas & CO Portfolio

Follow Landaas & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.